Katarina Luptakova's most recent trade in Xilio Therapeutics Inc was a trade of 451,885 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 451,885 | 451,885 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 16,625 | 33,250 | - | - | Restricted Stock Units | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 16,625 | 33,250 | - | - | Common Stock | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 625,000 | 625,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 106,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 106,000 | 106,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 44,210 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 44,210 | 44,210 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 16,625 | 16,625 | - | - | Common Stock | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 16,625 | 49,875 | - | - | Restricted Stock Units | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 59,333 | 59,333 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Luptakova Katarina | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 66,500 | 66,500 | - | - | Restricted Stock Units |